The global human genetics market size was valued at USD 34.41 billion in 2025 and is projected to grow from USD 37.93 billion in 2026 to USD 82.61 billion by 2034, registering a CAGR of 10.22% during the forecast period from 2026 to 2034. Asia Pacific dominated the human genetics market with a market share of 38.6% in 2025.
Human genetics is the branch of science that studies genes, heredity, and genetic variation in humans. It helps identify inherited disorders, supports disease diagnosis, enables genetic testing, and advances precision medicine. Growing demand for personalized healthcare, genomic research, and early disease detection is driving the growth of the human genetics market.
Download a Free Sample To learn more about this report,
Shift Toward Comprehensive Genomic Testing for Complex and Rare Diseases
The human genetics market is shifting from narrowly targeted genetic tests toward broader genomic approaches, particularly whole-exome and whole-genome sequencing. These methods can examine substantially larger portions of an individual’s DNA when conventional testing does not identify a disease-causing variant, increasing the role of comprehensive sequencing in clinical diagnosis and rare-disease evaluation.
Growing Integration of Genetic Testing Into Precision Healthcare
The market is increasingly moving toward using genetic information alongside clinical characteristics to guide disease diagnosis, treatment selection, and risk assessment. This is strengthening the role of genomic testing within precision medicine, where genetic variants can help clinicians identify appropriate therapies and improve treatment decisions for genetically influenced diseases and cancers.
Increasing Use of Genetic Testing for Rare and Undiagnosed Conditions
The increasing need to identify genetic causes of complex and rare diseases is driving demand for human genetics services and sequencing technologies. Healthcare providers can use exome or whole-genome sequencing when conventional testing fails to establish a diagnosis, creating demand for advanced sequencing, variant interpretation, and genetic analysis services.
Uncertain Clinical Interpretation of Genetic Variants Limits Broader Adoption
The large volume of variants identified through comprehensive sequencing can restrict clinical adoption because many detected genetic changes have uncertain relationships with disease. This creates additional requirements for expert interpretation, clinical validation, and genetic counseling, increasing the complexity of using genomic results in routine care.
Expansion of Genomic Data Platforms Creates Opportunities for Variant Interpretation Services
The growing volume of genomic information is creating opportunities for companies that provide bioinformatics, variant databases, interpretation software, and data-sharing infrastructure. Solutions that connect sequencing results with validated genetic databases can help laboratories and clinicians translate complex genomic data into clinically useful information.
Maintaining Analytical Accuracy Across Expanding Sequencing Workflows
The expansion of sequencing-based testing creates challenges in maintaining consistent analytical performance across laboratories, platforms, bioinformatics pipelines, and test types. Differences in sequencing methods and interpretation approaches can affect the reliability and clinical usefulness of results, increasing the need for standardized validation and quality controls.
Molecular Genetics Segment Dominated the Market with 39.6% Share in 2025
The molecular genetics segment dominated the human genetics market with a 39.6% market share in 2025, accounting for USD 13.63 billion, and is projected to grow at a CAGR of 9.04% during the forecast period. The segment's dominance is driven by the increasing use of molecular diagnostic techniques for identifying inherited disorders, cancer-related mutations, and rare genetic diseases. Growing adoption of next-generation sequencing (NGS), polymerase chain reaction (PCR), and precision medicine continues to strengthen the segment's leading position.
The cytogenetics, prenatal genetics, and symptom genetics segments also contribute significantly to the human genetics market. Rising demand for prenatal screening, chromosomal analysis, and genetic disease diagnosis continues to support the adoption of these testing methods across clinical and research applications.
Request Customizationto receive a tailored report.
Research Center Segment is Projected to Register the Fastest Growth at a CAGR of 8.76%
The research center segment is projected to register the fastest CAGR of 8.76% during 2026–2034. The segment accounted for 36.7% of the market, valued at USD 12.63 billion in 2025. Growth is driven by increasing investments in genomics research, expanding government funding, and rising collaborations between academic institutions and biotechnology companies. The growing focus on precision medicine, gene discovery, and advanced genomic technologies is further accelerating segment growth.
The hospital and forensic laboratories segments continue to contribute significantly to the human genetics market. Hospitals remain the largest end-user due to the widespread use of genetic testing for disease diagnosis and personalized treatment, while forensic laboratories continue to adopt genetic analysis for criminal investigations, identity verification, and legal applications.
Speak to an Analystto discuss market opportunities.
Asia Pacific dominated the human genetics market with a 38.6% share in 2025, accounting for USD 13.28 billion, and is projected to grow at a CAGR of 8.42% during the forecast period. Growth is driven by increasing investments in genomics research, expanding healthcare infrastructure, rising adoption of genetic testing, and growing government support for precision medicine initiatives. The rapid expansion of biotechnology and genomic sequencing capabilities continues to strengthen regional market growth.
Japan's market generated USD 3.05 billion in 2025. Increasing investments in precision medicine, expanding genomic research, growing adoption of next-generation sequencing technologies, and strong government support for healthcare innovation continue to drive market growth.
China's market accounted for USD 6.90 billion in 2025, representing the largest share within Asia Pacific. Rising government investments in genomics, expanding genetic testing services, increasing biotechnology research, and growing demand for personalized medicine continue to support market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
North America accounted for 31.4% of the human genetics market, reaching USD 10.80 billion in 2025, and is expected to register a CAGR of 9.18% during the forecast period. The regional market is driven by advanced genomic research infrastructure, widespread adoption of precision medicine, increasing healthcare expenditure, and the strong presence of leading biotechnology and genetic testing companies.
The U.S. market was valued at USD 9.18 billion in 2025, making it the largest contributor in North America. Strong investments in genomic sequencing, increasing demand for hereditary disease testing, expanding precision medicine programs, and continuous innovation in molecular diagnostics continue to drive market growth.
Canada's market reached USD 1.62 billion in 2025. Growing government support for genomic research, increasing adoption of genetic testing, expanding research collaborations, and rising awareness of personalized healthcare continue to support steady market expansion.
Europe held 20.7% of the human genetics market, valued at USD 7.12 billion in 2025, and is projected to grow at a CAGR of 7.96% during the forecast period. Increasing investments in genetic research, expanding rare disease screening programs, supportive healthcare policies, and growing adoption of advanced molecular diagnostics continue to accelerate regional market growth.
The U.K. market was valued at USD 1.71 billion in 2025. National genome sequencing initiatives, increasing investments in precision medicine, and expanding genetic testing services continue to support market growth.
Germany's market accounted for USD 2.14 billion in 2025. Strong biotechnology capabilities, increasing demand for molecular diagnostics, expanding genomic research, and growing healthcare investments continue to support market expansion.
Middle East & Africa accounted for 3.9% of the human genetics market, totaling USD 1.34 billion in 2025, and is anticipated to grow at a CAGR of 6.84% during the forecast period. Increasing investments in healthcare infrastructure, growing awareness of genetic disorders, expanding diagnostic services, and rising government initiatives supporting genomic medicine continue to drive regional market growth.
The UAE market was valued at USD 0.31 billion in 2025. Growing investments in genomic medicine, expanding precision healthcare initiatives, and increasing adoption of advanced genetic testing technologies continue to support market growth.
Africa's market reached USD 1.03 billion in 2025. Improving healthcare infrastructure, expanding genetic research programs, increasing awareness of inherited diseases, and growing international collaborations continue to create long-term growth opportunities across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Europe Tangential Flow Filtration Market Size, Share & Trends | Industry Report, 2034
Asia Pacific Genetic Testing Market Size, 2034
North America TB Diagnostics Market Size & Trends Analysis, 2034
U.S Direct to Consumer Laboratory Testing Market Size, Share and Forecast to 2034
Non-invasive Prenatal Testing Market Size, Share, Growth, 2034
Vaccines Market Size, Share, Growth, Analysis, Report, 2034
We are featured on:
sales@straitsresearch.com